Edited by Jame Abraham; report by Jane de Lartigue

Article

Venetoclax approved to treat CLL patients regardless of genotype

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: October 28, 2018

• Read More

Article

Nivolumab and ipilimumab combination promises new standard of care for advanced RCC

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: October 28, 2018

• Read More

Article

Neratinib extends adjuvant treatment of patients with HER2-positive breast cancer

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: August 26, 2018

• Read More

Article

More biosimilars reach the market in efforts to improve access and cut costs

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: August 26, 2018

• Read More

Article

First CAR T-cell therapy approvals bolster booming immunotherapy market

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: August 15, 2018

• Read More

Article

Lenalidomide becomes standard of care for multiple myeloma in the maintenance setting

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: August 2, 2018

• Read More

Article

Trastuzumab-dkst approval adds to the biosimilar cancer drug market

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: April 29, 2018

• Read More

Article

Pembrolizumab for dMMR/MSI-H tumors marks first tumor agnostic FDA approval

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: December 15, 2017

• Read More

Article

Brigatinib approval yields additional treatment options for crizotinib-resistant, ALK-positive NSCLC patients

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: December 15, 2017

• Read More

Article

PD-L1-targeting drug atezolizumab nabs approval for non-small cell lung cancer

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: December 1, 2017

• Read More

Article

Elotuzumab and ixazomib join the therapeutic arsenal for multiple myeloma

Author:

Edited by Jame Abraham; report by Jane de Lartigue

Publish date: August 24, 2016

• Read More